HIV-positive TB patients on ART (antiretroviral therapy) in Guinea-Bissau
Guinea-Bissau: HIV-positive TB patients on ART (antiretroviral therapy) was 74.0% in 2024. ▲ Rising
Latest (2024)
74.0%
Change on year
up 2.8%
World rank
121st
of 144 countries
All-time high
76.0%
in 2019
All-time low
7.4%
in 2012
Years of data
16
2005–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Guinea-Bissau, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on art (antiretroviral therapy) in Guinea-Bissau is 74.0%, measured in 2024.
The figure is up 2.8% on the previous year and up 174.1% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Guinea-Bissau peaked at 76.0% in 2019 and was at its lowest, 7.4%, in 2012.
Guinea-Bissau ranks 121st of 144 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 16 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Guinea-Bissau, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 30.0% | — |
| 2006 | 51.0% | +70.0% |
| 2007 | 13.0% | -74.5% |
| 2012 | 7.4% | -43.1% |
| 2013 | 20.0% | +170.3% |
| 2014 | 27.0% | +35.0% |
| 2015 | 41.0% | +51.9% |
| 2016 | 49.0% | +19.5% |
| 2017 | 45.0% | -8.2% |
| 2018 | 57.0% | +26.7% |
| 2019 | 76.0% | +33.3% |
| 2020 | 67.0% | -11.8% |
| 2021 | 75.0% | +11.9% |
| 2022 | 69.0% | -8.0% |
| 2023 | 72.0% | +4.3% |
| 2024 | 74.0% | +2.8% |
Guinea-Bissau compared with similar countries
- Guinea-Bissau's 74.0% is below the median for low income countries, which is 96.0%, 77% of the median. (23 countries reporting)
- Guinea-Bissau's 74.0% is below the median for Sub-Saharan Africa, which is 97.0%, 76% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 31.3% | 13.0% | 51.0% | 3 |
| 2010s | 40.3% | 7.4% | 76.0% | 8 |
| 2020s | 71.4% | 67.0% | 75.0% | 5 |
Countries ranked near Guinea-Bissau
More health data for Guinea-Bissau
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7721 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,070 deaths per 1,000 people (2090)
- Number of infants who die before age 1 941 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.899 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0664 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.8987 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Guinea-Bissau?
- Hiv-positive tb patients on art (antiretroviral therapy) in Guinea-Bissau was 74.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Guinea-Bissau?
- The highest recorded value was 76.0% in 2019.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Guinea-Bissau?
- The lowest recorded value was 7.4% in 2012.
- How does Guinea-Bissau rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Guinea-Bissau ranks 121st out of 144 countries with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Guinea-Bissau?
- Over the last ten years it is up 174.1%. The long-run trend across the full record is rising.
- Where does this Guinea-Bissau data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).